Z-1369-2024 Class II Ongoing

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-1369-2024 was initiated by Randox Laboratories Ltd. on Feb 14, 2024 and is designated Class II. Reason for recall: Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods The recall status is ongoing. Affected quantity: 666 units.

Recall details

Product Type
Devices
Report Date
Apr 3, 2024
Initiation Date
Feb 14, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
666 units

Product description

Cystatin C Calibrator - In vitro diagnostic (IVD) use in the calibration of the Randox Cystatin C assay on automated analysers Catalog Number: CVS 2699

Reason for recall

Cystatin C Calibrator Series CVS 2699, is running with a negative bias compared to other methods

Distribution pattern

US Nationwide distribution in the states of CA, IN.

Code information

GTIN: 05055273207439 (1) Batch 600957 Lot 1378CY - 1382CY (2) Batch 621809, 621815 Lot 1403CY - 1407CY (3) Batch 650533 Lot 1414CY - 1418CY

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1369-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1369-2024. Report a data issue: hello@regdatalab.com.